Royal Bank of Canada’s Quantum Biopharma Ltd. Class B Subordinate Voting Shares QNTM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2K | Buy |
82
+63
| +332% | +$1.54K | ﹤0.01% | 6449 |
|
2025
Q1 | $0 | Sell |
19
-360
| -95% | – | ﹤0.01% | 6743 |
|
2024
Q4 | $1K | Buy |
379
+272
| +254% | +$718 | ﹤0.01% | 6329 |
|
2024
Q3 | $0 | Buy |
107
+86
| +410% | – | ﹤0.01% | 7035 |
|
2024
Q2 | $0 | Sell |
21
-72
| -77% | – | ﹤0.01% | 7098 |
|
2024
Q1 | $4K | Buy |
93
+55
| +145% | +$2.37K | ﹤0.01% | 6094 |
|
2023
Q4 | $2K | Buy |
38
+24
| +171% | +$1.26K | ﹤0.01% | 6312 |
|
2023
Q3 | $1K | Sell |
14
-19
| -58% | -$1.36K | ﹤0.01% | 6466 |
|
2023
Q2 | $2K | Buy |
33
+5
| +18% | +$303 | ﹤0.01% | 6456 |
|
2023
Q1 | $3K | Sell |
28
-12
| -30% | -$1.29K | ﹤0.01% | 6329 |
|
2022
Q4 | $2K | Buy |
40
+2
| +5% | +$100 | ﹤0.01% | 6484 |
|
2022
Q3 | $2K | Sell |
38
-15
| -28% | -$789 | ﹤0.01% | 6589 |
|
2022
Q2 | $3K | Buy |
53
+17
| +47% | +$962 | ﹤0.01% | 6403 |
|
2022
Q1 | $3K | Buy |
36
+25
| +227% | +$2.08K | ﹤0.01% | 6926 |
|
2021
Q4 | $1K | Sell |
11
-3
| -21% | -$273 | ﹤0.01% | 7016 |
|
2021
Q3 | $1K | Hold |
14
| – | – | ﹤0.01% | 6990 |
|
2021
Q2 | $1K | Buy |
14
+9
| +180% | +$643 | ﹤0.01% | 6849 |
|
2021
Q1 | $1K | Sell |
5
-10
| -67% | -$2K | ﹤0.01% | 6829 |
|
2020
Q4 | $1K | Sell |
15
-3
| -17% | -$200 | ﹤0.01% | 6421 |
|
2020
Q3 | $3K | Sell |
18
-18
| -50% | -$3K | ﹤0.01% | 5773 |
|
2020
Q2 | $9K | Buy |
36
+25
| +227% | +$6.25K | ﹤0.01% | 5399 |
|
2020
Q1 | $2K | Buy |
+11
| New | +$2K | ﹤0.01% | 5841 |
|